Walgreens Launches Colorectal Cancer Screening Initiative
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 13 2026
0mins
Source: Yahoo Finance
- Screening Tool Launch: Walgreens collaborates with Exact Sciences to introduce the Cologuard® test, providing a streamlined pathway for eligible average-risk patients to access colorectal cancer screening, which is expected to significantly reduce mortality rates by supporting earlier detection.
- Awareness Enhancement: During Colorectal Cancer Awareness Month, Walgreens aims to help over one-third of U.S. adults update their screenings by integrating non-invasive options, which is anticipated to improve patient health outcomes and reduce healthcare burdens.
- Convenient Screening Experience: The Cologuard test offers a non-invasive screening method for adults aged 45 and older, requiring no special diet or preparation, and is covered by most insurance, likely encouraging more patients to participate proactively in their health screenings.
- Community Health Connection: By partnering with Workflow Services, Walgreens is advancing a nationwide colorectal cancer screening initiative that enhances patient access to clinical services through pharmacies, further solidifying its role as a key community health service provider.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
